Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/05
End: 04/30/09
Due: 04/30/10
Phase: N/A
Priority: Normal
Start: 03/31/04
End: 12/31/05
Due: 12/31/06
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Amonafide in Combination With Cytarabine in Secondary AML | NCT00273884 | Xanthus Pharmaceuticals, Inc. | user2@example.com | None | 2005-08-31 | 2009-04-30 | 2010-04-30 | - | - | 2025-07-14 |
| Study of Individualized Amonafide to Treat Prostate Cancer | NCT00087854 | Xanthus Pharmaceuticals, Inc. | user2@example.com | None | 2004-03-31 | 2005-12-31 | 2006-12-31 | - | - | 2025-07-14 |